用个性化医学治疗心血管疾病
Ishu Garg1, Harish Kumar1, Madhu Verma2
1Sardar Bhagwan Singh Post Graduate Institute of Biomedical Sciences and Research, Balawala, Dehradun, Uttarakhand, 248161, India.
Cardiovascular & hematological disorders drug targets
|February 27, 2025
概括
个性化心脏病学使用基因组学和分子诊断来定制心血管治疗. 这种方法旨在通过了解个体患者病理学来改善心脏病的诊断,预防和治疗.
科学领域:
- 心血管医学 心血管医学
- 基因组学就是基因组学.
- 蛋白质组学是指蛋白质组学.
背景情况:
- 个性化医疗为个体患者提供量身定制的治疗.
- 个性化心脏病学是心血管疾病的一个新兴领域,集成基因组学和蛋白质组学.
- 分子诊断和生物标志物对于将诊断与心血管疾病治疗联系起来至关重要.
研究的目的:
- 审查个性化心血管疾病治疗的参数.
- 突出分子遗传学在推进个性化心脏病学的作用.
- 讨论个性化方法在诊断,预防和治疗心血管疾病方面的潜力.
主要方法:
- 基因组学和蛋白质组学分析.
- 生物标志物的识别和利用.
- 生物信息学用于风险分层.
- 整合3D打印,药物治疗,手术和生活方式修改.
主要成果:
- 个性化心脏病学可以为心血管疾病提供量身定制的诊断和治疗.
- 了解个体病理和遗传因素是开发向治疗的关键.
- 生物信息学可以增强心血管疾病风险预测算法.
结论:
- 个性化心脏病学在治疗心血管疾病方面具有重大前景.
- 克服科学和政策障碍对于临床实施至关重要.
- 改善疾病分类和对个体差异的理解将推动有针对性的治疗.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Assessment of the Cardiovascular System I: Subjective Data
261
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
261
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
126
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
126
Pathophysiology of Cardiac Performance
509
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
509
Increased pulse rate
635
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
635


